Company: LRHC
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-079984
Chunk: 24

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-22
Form: 424B3
Chunk 24
---
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 are issued by us.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Terms of the Offering                         |     | The Selling Stockholder will determine when and how it will dispose of the shares of common stock registered under this Prospectus. The Selling Stockholder will be able to sell all of its shares for so long as the registration statement of which this Prospectus forms a part is available for use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Use of Proceeds                               |     | We will not receive any of the proceeds from the sales of common stock by the Selling Stockholder pursuant to this Prospectus. We may receive up to $150,000,000 aggregate gross proceeds under the Facility from any sales of shares of our common stock that we make to the Selling Stockholder pursuant to the Facility, assuming that we sell the full amount of our common stock that we have the right, but not the obligation, to sell to the Selling Stockholder under the Facility, and that we comply with the other conditions of the Facility.                                                                                                                                                                                                                             |
| Risk Factors                                  |     | An investment in our common stock involves a high degree of risk and could result in a loss of your entire investment. Further, the issuance to, or sale by, the Selling Stockholder of a significant amount of shares being registered in the registration statement, of which this Prospectus forms a part, at any given time could cause the market price of our common stock to decline and to be highly volatile, and we do not have the right to control the timing and amount of any sales by the Selling Stockholder of such shares. Prior to making an investment decision, you should carefully consider all of the information in this Prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 14. |
| Trading Symbol on the Nasdaq Capital Market   |     | LRHC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

| (1) | Based on 1,223,918 shares                                                                     
 of common stock outstanding as of August 18, 2025 and excludes the following as of such date: |

| ● | 1,389 shares of our common stock issuable upon the exercise of warrants outstanding, at a weighted average exercise price of $796.75 per share; |

| ● | 54,155 shares of our common stock issuable upon the exercise of stock options outstanding, at a weighted average exercise price of $116.92 per share; |

| ● | 7,460